Genetic information is starting to become a key factor in the testing of selected men for their risk for certain types of prostate cancer, and for the potential value of certain therapeutic agents in the treatment of prostate cancer in selected individuals. While we are still a very long way from truly personalized diagnosis and […]![]()
